Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
JAMA Psychiatry|October 22, 2025
Serial Ketamine Infusions as Adjunctive Therapy to Inpatient Care for Depression: The KARMA-Dep 2 Randomized Clinical TrialAna Jelovac, Cathal McCaffrey, Masashi Terao, et al.
The Journal of Biological Chemistry|July 29, 2005
ALS2/Alsin regulates Rac-PAK signaling and neurite outgrowthElizabeth L Tudor, Michael S Perkinton, Anja Schmidt, et al.
Journal of Affective Disorders|February 15, 2020
Development of the Ketamine Side Effect Tool (KSET)Brooke Short, Vanessa Dong, Verònica Gálvez, et al.
Human Molecular Genetics|August 30, 2007
Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria contentKurt J De Vos, Anna L Chapman, Maria E Tennant, et al.
Journal of Affective Disorders|April 11, 2022
The Ketamine Side Effect Tool (KSET): A comprehensive measurement-based safety tool for ketamine treatment in psychiatryAdam Bayes, Brooke Short, Carlos A Zarate, et al.
Molecular Psychiatry|October 15, 2021
Microglia and their LAG3 checkpoint underlie the antidepressant and neurogenesis-enhancing effects of electroconvulsive stimulationNeta Rimmerman, Hodaya Verdiger, Hagar Goldenberg, et al.
Biological Psychiatry|December 27, 2021
Interrogating Associations Between Polygenic Liabilities and Electroconvulsive Therapy EffectivenessJurjen J Luykx, Dore Loef, Bochao Lin, et al.
Molecular Psychiatry|September 7, 2022
International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderatorsRebecca B Price, Nicholas Kissel, Andrew Baumeister, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 6, 2019
International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic)Takahiro Soda, Declan M McLoughlin, Scott R Clark, et al.
Pageof 15